References
- Amundsen E., Svendsen L. A new method for plasma kallikrein utilizing a synthetic chromogenic substrate. New methods for the analysis of coagulation using chromogenic substratesEd. I. Witt, Walter de Gruyter. 1977; 211
- Aurell L., Friberger P., Karlsson G., Claeson G. A new sensitive and highly specific chromogenic peptide substrate for factor Xa. Thromb. Res 1977; II: 595–609
- Bang N. U., Mattler L. E. Serine Protease Specificity for Peptide Chromogenic Substrates. Thromb. Haemost 1977; 38: 776–92
- Burrowes C. E., Habal F. M., Movat H. Z. The inhibition of human plasma kallikrein by antithrombia III. Thromb. Res 1975; 7: 175–83
- Claeson G., Friberger P., Knös M., Eriksson E. Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase. Haemostasis 1978; 7: 76–78
- Donaldson V. H., Glueck H. I., Miller M. A., Movat H. Z., Habal F. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis. J. Lab. Clin. Med 1976; 87: 327–37
- Egberg N., Bergström K. Studies on assays for plasma prekallikrein and for the monitoring of cumarol therapy. Haemostasis 1978; 7: 85–91
- Friberger P., Knös M., Gustafsson S., Aurell L., Claeson G. A new specific substrate for the determination of plasmin activity. Chromogenic Substrates, V. V. Kakkar. Churchill Livingstone, In press
- Gallimore T. M., Fareid E., Stormorken H. The purification of a human plasma kallikrein with weak plasminogen activator activity. Thromb. Res 1978; 12: 409–20
- Griffin J. H. Role of surface-dependent activation of Hageman factor (Blood coagulation Factor XII). Proc. Natl. Acad. Sci 1978; 75: 1998–2002
- Kaplan A. P., Meier H. L., Mandle R. The Hageman factor dependent pathway of coagulation, fibrinolysis and kinin generation. Seminars in Thrombosis and Haemostasis 1976; 3: 1–26
- Kluft C. Blood Fibrinolysis. Preactivators and activators in human plasma. Thesis, Dutch Efficiency Bureau-Pijnacker. 1978; 104
- Meier H. L., Scott C. F., Mandle R., Webster M. E., Pierce J. V., Colman R. W., Kaplan A. P. Requirements for contact activation of human Hageman factor. Ann. N.Y. Acad. Sci 1977; 283: 93–103
- Schreiber A. D. Plasma inhibitors of the Hageman factor dependent pathways. Seminars in Thrombosis and Haemostasis 1976; 3: 43–51
- Wiggins R. C., Bouma B. N., Cochrane C. G., Griffin J. H. Role of high-molecular-weight kininogen in surface binding and activation of coagulation Factor XI and prekallikrein. Proc. Natl. Acad. Sci 1977; 74: 4634–40